HUTCHMED (LON:HCM) Shares Pass Above 200-Day Moving Average of $268.65

HUTCHMED (China) Limited (LON:HCM) shares passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 268.65 ($3.37) and traded as high as GBX 316 ($3.97). HUTCHMED shares last traded at GBX 310 ($3.89), with a volume of 239,919 shares traded.

HUTCHMED Stock Performance

The company has a debt-to-equity ratio of 11.59, a quick ratio of 2.97 and a current ratio of 2.72. The business has a 50-day moving average price of GBX 268.34 and a 200 day moving average price of GBX 268.65. The stock has a market capitalization of £2.65 billion, a P/E ratio of 3,100.00 and a beta of 0.68.

About HUTCHMED

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors.